A new report was launched this week on ‘Digital health: Creating a new growth industry for Australia’, by ANDHealth, highlighting what is required to prosper a thriving, international digital health industry.
The whitepaper was developed following a 2017 series of roundtable consultations involving a diverse group of senior executives from across the Australian healthcare industry. The roundtables explored the strengths, opportunities, constraints and barriers to the commercialisation of evidence based digital health technologies in Australia.
The four key areas explored were:
- Technology development;
- Regulation;
- Investment; and
- Market entry/Implementation.
Across each theme outlined above, this whitepaper poses recommendations intended to represent tangible activities for both government and industry to partner on to accelerate the growth of the sector in Australia.
ANDHealth Managing Director Bronwyn Le Grice says, “Our report makes the case that Australia has the opportunity right now to develop an internationally competitive digital health industry which would complement and leverage our traditionally strong biopharmaceutical and medical device sectors.”
ANDHealth is a not-for-profit company that was established in 2017 by a consortium of industry partners, including AusBiotech as a foundation member. The goal of ANDHealth is to develop a more effective ecosystem to support Australian digital health companies as they navigate the commercialisation pathway to institutional investment and international market entry. The formation of the organisation was catalysed by the incorporation of and first funding rounds of the Federal Government’s Industry Growth Centres program, specifically MTPConnect.
Read the report in full here.